Yashraj Biotechnology Ltd. (YBL) is an emerging CRO focusing on preclinical cancer models & one of the largest manufacturers and suppliers of human native antigens to In Vitro Diagnostic players all over the world. YBL has developed preclinical cancer models for end-to-end solutions in drug discovery and development including target identification and lead validation, drug efficacy testing, safety profiling, target expansion as well as disease modelling. YBL offers unique cancer models that recapitulate clinical response of known drugs and thus show promise for testing INDs. Models include cancer organoids using primary cells & iPSC-derived organoids from patients with cancers originating in different tissues. These cancer platforms are available in 2D as well as 3D formats for drug testing and disease modelling.